文献速递介入儿科影像腹部US

Fontan术后患者的经皮肝活检

Percutaneous liver biopsy in Fontan patients.
PubMed 文献 · Pediatr Radiol · 2018-11-30

这项回顾性研究分析了67例单心室Fontan术后患者共68次超声引导下经皮肝活检,技术成功率100%,组织取材合格率100%;唯一并发症为出血(7.4%),其中轻微出血5.9%、严重出血1.5%,与无Fontan患者的肝活检出血率相似;Fontan压力与出血风险无关。

要点

  • Fontan术后患者经皮肝活检技术成功率和组织取材合格率均为100%。
  • 出血是唯一并发症(7.4%),轻微出血5.9%、严重出血1.5%,部分表现为迟发出血。
  • 活检后即刻血红蛋白下降≥2 mg/dL对出血的敏感度低。

核心结论

  • Fontan患者经皮肝活检可安全实施,技术成功率高且并发症率未增加;建议细致操作和密切观察以减少活检后并发症;右心压力升高程度与出血无关。

研究设计与样本

  • 回顾性研究,纳入67例单心室心脏疾病Fontan术后患者共68次超声引导下经皮肝活检,于一家儿科三级医疗中心介入放射科在3年期间完成;分析活检操作报告、病理报告、心脏血管造影压力测量和实验室检查数据。

诊断标准与关键数值

  • 技术成功率为100%,组织足以评估肝病者为100%,包括单次穿刺活检。
  • 最常用同轴活检系统为18G全芯活检针经17G导入套管,41/68例(60%)。
  • 最常见槽长度为2.3 cm,37例(54%)使用。
  • 穿刺1次者27例(40%),穿刺2次者30例(44%);明胶海绵窦道栓塞52例(76%)。
  • 出血并发症5/68例(7.4%),其中轻微4例(5.9%)、严重1例(1.5%)。

临床应用与阅片要点

  • 活检前常规暂停抗凝,未因此发生心脏并发症。
  • 活检后即刻血红蛋白下降≥2 mg/dL对出血的敏感度低。
  • 5例出血中3例表现为迟发出血。
  • 作者建议细致操作和密切观察以减少活检后并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Patients who have undergone the Fontan operation for palliation of congenital heart disease with single-ventricle pathophysiology are at high risk for developing progressive liver fibrosis. Pathological assessment from percutaneous liver biopsy is central to the management of Fontan-associated liver disease, but liver biopsy in this vulnerable population poses unique challenges and potential risks.

OBJECTIVE: This retrospective study describes our experience with percutaneous liver biopsy performed to assess changes of Fontan-associated liver disease, with particular regard to procedural outcomes.

MATERIALS AND METHODS: Data from liver biopsy procedure reports, pathology reports, cardiac angiography pressure measurements and laboratory values of patients with single ventricle heart disease after the Fontan operation who underwent ultrasound-guided percutaneous liver biopsy performed in interventional radiology at a pediatric tertiary care center during a 3-year period were retrospectively analyzed.

RESULTS: Sixty-eight liver biopsies were performed in 67 patients (mean age: 20.2 years, range: 7.2-39 years). The technical success rate was 100%, and tissue was adequate for assessing liver disease in 100% of the procedures, including biopsies performed with a single pass. Anticoagulation was routinely suspended before biopsy, and no cardiac complications were encountered due to this suspension. A coaxial biopsy system using an 18-gauge (G) full-core instrument through a 17-G introducer trocar was most commonly used, in 41/68 cases (60%). The most common trough length was 2.3 cm, used in 37 cases (54%). One pass was made in 27 procedures (40%) and two passes in 30 (44%); tract embolization with gelatin sponge was performed in 52 (76%). The only complication was hemorrhage, which occurred in 5/68 (7.4%) of the biopsies, minor in four (5.9%) and major in one (1.5%) -- similar to rates reported for liver biopsy in non-Fontan patients. Hemorrhage had a delayed presentation in three of these five cases. Immediate post-biopsy hemoglobin decrease of ≥2 mg/dL showed a low sensitivity for hemorrhage. The mean Fontan pressure measured during cardiac angiography was 13.8 mmHg, and shunt pressures were not associated with an increased risk of hemorrhage.

CONCLUSION: Percutaneous liver biopsy in Fontan patients can be performed safely with high technical success rates and without increased complication rates. Meticulous technique and close observation are recommended to reduce post-biopsy complications. The degree of right heart pressure elevation was not associated with hemorrhage.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. Srinivasan A, Guzman AK, Rand EB, et al. Percutaneous liver biopsy in Fontan patients. Pediatr Radiol. 2018. PMID: 30506328. doi:10.1007/s00247-018-4311-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。